Navigation Links
Pathways Pharmacist Denise Schoenberger Honored for Healthcare Excellence by Silicon Valley Business Journal

Sunnyvale, CA (PRWEB) August 27, 2013

Denise Schoenberger, a clinical pharmacist at Pathways Home Health & Hospice, was honored by the Silicon Valley Business Journal for Excellence in Healthcare for her role in establishing the Pharmacist Assisted Transition Home (PATH) program. PATH is an innovative medication management program where a pharmacist makes house calls as part of a home health nursing team that provides patient care from hospital to home. Schoenberger was one of six healthcare professionals recognized by the Silicon Valley Business Journal for leadership and creativity in Santa Clara County.

PATH is a joint venture with Sequoia Hospital, a Dignity Health member, and has been successfully keeping at risk patients in their homes and preventing them from being re-hospitalized. Pathways Home Health & Hospice has been affiliated with Sequoia and El Camino Hospitals since 1986.

As the program’s pharmacist, Schoenberger visits patients at Sequoia Hospital when they are preparing for discharged. She provides them with medication education and guidance to prepare them for a smooth transition to home. She then visits the same patients again in their homes, where she coaches both the patients and their caregivers about medication management and how to take an active role in their healthcare.

“Denise is a key member of our home health nursing team,” said Georgia Rock, COO at Pathways Home Health & Hospice. “She shares her pharmacological expertise to create the best care plan possible for our patients. Her approach to patient care has resulted in many of our patients staying home and avoiding re-hospitalization. This award is well deserved.”

Pathways Home Health & Hospice has several transition care programs in addition to PATH. Many of these programs address the unique needs of older adults suffering from chronic illness. Without focused intervention, these patients are at a higher risk of medical emergencies leading to re-hospitalization. Pathways has implemented these evidence-based programs to help this high risk group of patients.

About Pathways Home Health & Hospice

Pathways Home Health & Hospice is a non-profit, community-based organization with more than 36 years of assisting Bay Area families. Pathways was founded in 1977 by a group of Stanford physicians and community members who saw the need for professional care at home. That first year, Pathways served 12 patients. Pathways now serves over 5,000 families a year in San Francisco, Alameda, Santa Clara, San Mateo and Contra Costa Counties.

Affiliated with El Camino and Sequoia Hospitals since 1986, Pathways Home Health & Hospice is accredited by The Joint Commission, and is a member of the Visiting Nurse Association of America, California Hospice & Palliative Care Association, and the California Association of Health Services at Home. Pathways Home Health & Hospice is a designated 2012 HomeCare Elite Agency for Quality Care.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Los Altos Community Foundation Grant Supports Pathways Hospice
2. Pathways Bronwyn Calkins Honored with the 2013 Lillian O’Brien Award for Home Health Excellence
3. Pathways Hospice Offers Reflection, Comfort and Healing at Evening of Remembrance Memorial Service in Los Altos, California
4. Pathways Hospice Recognizes Sponsors of Bridge to Caring 2013
5. Details of gene pathways suggest fine-tuning drugs for child brain tumors
6. Tips for Making the Holidays Safer and Calmer for Dementia Patients from Pathways Home Health & Hospice
7. Pathways Home Health & Hospice Receives 2012 HomeCare Elite Top Honor for Quality Care
8. Investigational agent targets gene signaling pathways to improve response for patients with CLL
9. Optogenetics illuminates pathways of motivation through brain, Stanford study shows
10. How tumor cells create their own pathways
11. Following the genomic pathways to stop the spread of cancer
Post Your Comments:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... BALTIMORE (PRWEB) , ... October 12, 2017 , ... ... average of $3,296 in property taxes a year. In some states—like New York, ... higher. , By contrast, many overseas retirement havens have extremely low property-tax rates, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: